ArticleClinical and molecular hepatology2026

Evaluating treatment response thresholds for cost-effective treatment in metabolic dysfunction-associated steatotic liver disease.

Eileen L Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.